Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
ADAR1 affects HCV infection by modulating innate immune response.
Positioning Europe for the EPITRANSCRIPTOMICS challenge.
CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Antiviral treatment strategies based on gene silencing and genome editing.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.
SAMHD1 is active in cycling cells permissive to HIV-1 infection.
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages.
Highlights of the 30th International Conference on Antiviral Research.
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.